Gene dysregulation of ATP2C2 has been linked to breast cancers: ATP2C2 (also known as SPCA2) promotes tumor growth by increasing Ca2+ entry through activation of the Orai1 calcium channel (6). Here, ATP2C2 is linked to neoplasm.